Bliss GVS Pharma Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

21 Nov 2017 | 03:59 PM

194.35
-2.65 (-1.35%)

  • Outperforms Index

    62.64%

    Return (1Y)

    Beaten S&P BSE Healthcare by 70.73%

  • More Volatile

    2.5%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 1.44%

  • Consistent Performer

    8/12

    Months

    beaten S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

203

202.75

118

117.50

News & Announcements

Price vs Volume

Stock Trivia

  • Bliss GVS Pharma Ltd is trading very close to its 52 Week High

  • FII shareholding in Bliss GVS Pharma Ltd has increased by 6.93% since past 3 Months

  • MF shareholding in Bliss GVS Pharma Ltd has increased by 17.61% since past 3 Months

  • FII shareholding in Bliss GVS Pharma Ltd has increased by 38.84% since past 1 Year

Loading...